Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Grant or award Chief Commercial Officer acquired 26,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 28,000 shares (grant or award)
  3. 4 Grant or award VP, Controller acquired 9,500 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 26,000 shares (grant or award)
  5. 4 Grant or award CEO and President acquired 87,000 shares (grant or award)
  6. 4 Grant or award Chf Scientific Operations Off acquired 30,000 shares (grant or award)
  7. 4 Gift CEO and President gave 300,000 shares (gift)
  8. 4 Gift CEO and President gave 18,667 shares (gift)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Chief Commercial Officer acquired 50,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4/A Open-market buy Director bought 20,000 shares at $3.19 ($63,800)
  20. 4 Open-market buy Director bought 20,000 shares at $3.19 ($63,800)

Page 2 of 20 · 382 filings